抗菌微生物及拮抗性代谢产物的种类和应用

2009442ChinMedBiotechnol,April2009,Vol.4,No.2137··30bacteriophage2[1]virulentphagetemperatephagelysogenicphageprophage30[1][2][2-5][6][4-5][7][8][9]3probiotics30871395/[e-mail]2008-12-171382009442ChinMedBiotechnol,April2009,Vol.4,No.2[8][10][11][12]pHEh6DM423SA38Nisin[13]antibioticBacteriocin[14]S4[15]NisinLaetacinLaeloeinHelvetieinFermentieinSakeeinLaetieinPlantaeinSubtieinNisinNisin[16][17][18]2009442ChinMedBiotechnol,April2009,Vol.4,No.2139[19][1]LinHP.Progressinresearchofbiocontrolbybacterphage.JZhanjiangNormalColl,2007,28(3):91-94.(inChinese)..,2007,28(3):91-94.[2]SunW,ZhuCB.Byusingbacteriophagetreatbacteriuminfection.WorldNotesAntibiot,2005,26(2):54-58,69.(inChinese),..,2005,26(2):54-58,69.[3]vonBodmanSB,WilleyJM,DiggleSP.Cell-cellcommunicationinbacteria:unitedwestand.JBacteriol,2008,190(13):4377-4391.[4]CapparelliR,ParlatoM,BorrielloG,etal.ExperimentalphagetherapyagainstStaphylococcusaureusinmice.AntimicrobAgentsChemother,2007,51(8):2765-2773.[5]McVayCS,VelásquezM,FralickJA.PhagetherapyofPseudomonasaeruginosainfectioninamouseburnwoundmodel.AntimicrobAgentsChemother,2007,51(6):1934-1938.[6]GuentherS,HuwylerD,RichardS,etal.VirulentbacteriophageforefficientbiocontrolofListeriamonocytogenesinready-to-eatfoods.ApplEnvironMicrobiol,2009,75(1):93-100.[7]JohnsonRP,GylesCL,HuffWE,etal.Bacteriophagesforprophylaxisandtherapyincattle,poultryandpigs.AnimHealthResRev,2008,9(2):201-215.[8]KurzępaA,DąbrowskaK,SkaradzińskiG,etal.Bacteriophageinteractionswithphagocytesandtheirpotentialsignificanceinexperimentaltherapy.ClinExpMed,2009,30.[9]HuB,WangJ,YanQ,etal.ApplicationofphagesinthetreatmentofbacteremiacausedbyImipenem-resistantPseudomonasaeruginosa.ChinJMicrobiolImmunol,2006,26(5):438-441.(inChinese),,,..,2006,26(5):438-441.[10]HozyaszKK.Promissingroleofprobioticsinpreventionofsmoking-relateddiseases.PrzeglLek,2008,65(10):706-708.[11]VouloumanouEK,MakrisGC,KarageorgopoulosDE,etal.Probioticsforthepreventionofrespiratorytractinfections:asystematicreview.IntJntimicrobAgents,2009,27.[12]JanduN,ZengZJ,Johnson-HenryKC,etal.ProbioticsprevententerohaemorrhagicEscherichiacoliO157:H7-mediatedinhibitionofinterferon-{gamma}-inducedtyrosinephosphorylationofSTAT-1.Microbiology,2009,155(Pt2):531-540.[13]WalterJ.Ecologicalroleoflactobacilliinthegastrointestinaltract:implicationsforfundamentalandbiomedicalresearch.ApplEnvironMicrobiol,2008,74(16):4985-4996.[14]ZhangJF,LiQX.Studyandapplicationofbacteriocin.FeedInd,2008,29(4):7-8.(inChinese),..,2008,29(4):7-8.[15]ZethK,RömerC,PatzerSI,etal.CrystalstructureofcolicinM,anovelphosphatasespecificallyimportedbyEscherichiacoli.JBiolChem,2008,283(37):25324-25331.[16]SimovaED,BeshkovaDB,DimitrovZhP.CharacterizationandantimicrobialspectrumofbacteriocinsproducedbylacticacidbacteriaisolatedfromtraditionalBulgariandairyproducts.JApplMicrobiol,2009,106(2):692-701.[17]RiaziS,WirawanRE,BadmaevV,etal.Characterizationoflactosporin,anovelantimicrobialproteinproducedbyBacilluscoagulansATCC7050.JApplMicrobiol,2009,2.[18]SvetochEA,LevchukVP,PokhilenkoVD,etal.Inactivatingmethicillin-resistantStaphylococcusaureusandotherpathogensbyuseofbacteriocinsOR-7andE50-52.JClinMicrobiol,2008,46(11):3863-3865.[19]ChenLY,WenMN.WesternEuropemedicineresearchanddevelopmentinspection.ChinMedBiotechnol,2007,2(1):71-73.(inChinese),..,2007,2(1):71-73.………………………………………………………………